Can I use a non-contrast computed tomography (CT) of the abdomen and pelvis to evaluate for kidney stones and pancreatitis?

Yes, non-contrast CT abdomen/pelvis is excellent for kidney stones but suboptimal for pancreatitis evaluation.

For simultaneous evaluation of both kidney stones AND pancreatitis, you should order CT abdomen/pelvis WITH IV contrast, as this provides adequate sensitivity for clinically significant stones while properly characterizing pancreatic inflammation and necrosis.

Kidney Stone Detection

Non-contrast CT is the reference standard for urolithiasis with 97% sensitivity 1. The ACR Appropriateness Criteria (2023) explicitly state that virtually all renal calculi are radiopaque on CT, allowing accurate detection even without IV contrast 1.

Key Performance Metrics:

• Detects stones as small as 1-2 mm
• Low-dose protocols (<3 mSv) maintain 97% sensitivity and 95% specificity 1
• Visualizes secondary signs: hydronephrosis, perinephric inflammation, ureteral dilatation
• Accurately measures stone size and location for treatment planning

Pancreatitis Evaluation - The Critical Limitation

Non-contrast CT significantly underperforms for pancreatitis assessment. While it can detect pancreatic enlargement and peripancreatic fluid, it cannot:

• Distinguish viable pancreatic tissue from necrosis (requires contrast enhancement)
• Identify vascular complications (pseudoaneurysms, venous thrombosis)
• Characterize inflammatory versus hemorrhagic collections
• Assess extent of pancreatic perfusion defects

The 1989 study showed that non-contrast CT's hypodensity measurements showed no significant correlation with pathologically-determined extent of pancreatic necrosis 2. This is clinically critical because necrotizing pancreatitis requires different management than interstitial pancreatitis.

The Practical Solution

Order CT abdomen/pelvis WITH IV contrast when evaluating both conditions simultaneously:

Why This Works:

1. Stones ≥6 mm detected with 98% sensitivity on contrast-enhanced CT 1 - these are the clinically significant stones unlikely to pass spontaneously

2. Proper pancreatitis staging requires contrast to identify necrosis, vascular complications, and guide intervention decisions

3. Contrast-induced AKI concerns are overstated: The 2023 randomized controlled trial found that when adjusted for disease severity, CECT showed no significant difference in AKI rates compared to non-contrast CT in acute necrotizing pancreatitis 3

Important Caveats:

• Small stones (<3 mm) may be missed on contrast CT, but these typically pass spontaneously and rarely require intervention
• If the patient has contraindications to IV contrast (severe renal impairment, contrast allergy), obtain non-contrast CT first for stones, then consider MRI abdomen with contrast for pancreas evaluation 4
• In pregnant patients, use MRI without and with contrast as the initial study 4

Clinical Algorithm:

If suspecting both conditions:

1. Order CT abdomen/pelvis WITH IV contrast (portal venous phase)
2. Radiologist can assess for stones on soft tissue windows and pancreatic enhancement
3. Clinically significant stones (≥6 mm) will be detected
4. Pancreatic necrosis, inflammation, and complications properly characterized

If ONLY kidney stones suspected:

1. Order low-dose non-contrast CT abdomen/pelvis
2. Minimizes radiation exposure (can be <3 mSv)
3. Maximum sensitivity for all stone sizes

If ONLY pancreatitis suspected:

1. Order CT abdomen/pelvis WITH IV contrast
2. Essential for severity grading and detecting complications

The dual-pathology scenario requires prioritizing the modality that adequately addresses both conditions, which is contrast-enhanced CT 1, 4, 3.